NCT04026360View on ClinicalTrials.gov

Impact of Early Lung Physiology, Viral Infections and the Microbiota on the Development and Progression of Lung Disease in Children With Cystic Fibrosis

RecruitingOBSERVATIONAL
Enrollment

500

Participants

Timeline

Start Date

July 1, 2011

Primary Completion Date

August 31, 2050

Study Completion Date

December 31, 2050

Conditions
Confirmed Diagnosis of Cystic Fibrosis
Interventions
OTHER

no intervention

Trial Locations (1)

3010

RECRUITING

University Children's Hospital Bern, Bern

All Listed Sponsors
collaborator

University Children's Hospital, Zurich

OTHER

collaborator

Centre Hospitalier Universitaire Vaudois

OTHER

collaborator

Kantonsspital Aarau

OTHER

collaborator

University Children's Hospital Basel

OTHER

lead

Insel Gruppe AG, University Hospital Bern

OTHER

NCT04026360 - Impact of Early Lung Physiology, Viral Infections and the Microbiota on the Development and Progression of Lung Disease in Children With Cystic Fibrosis | Biotech Hunter | Biotech Hunter